WilliamLReadMD

Oncology • Atlanta, GA

Associate Professor, Hematology and Medical Oncology, Emory University School of Medicine

Join to view full profile

Dr. Read is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Read's full profile

Already have an account?

Office
1365 Clifton Rd Ne
Clinic C Second Floor
Atlanta, GA 30322
Phone+1 404-778-1900

Fax+1 404-778-5676
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1999 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1996 - 1999
University of Nebraska College of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 2003 - Present
GA State Medical License 2011 - 2025

Awards, Honors, & Recognition

Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com

Clinical Trials

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer Start of enrollment: 2006 May 01
Withdrawn
Phase 2
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer Start of enrollment: 2006 May 01
Unknown status
Not Applicable
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer Start of enrollment: 2006 Sep 01
Unknown status
Phase 1, Phase 2
A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 2012 Sep 27
Completed
Phase 2
A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma Start of enrollment: 2014 Jan 01
Completed
Phase 2
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma Start of enrollment: 2021 Jan 15
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity.
Menon, A., Enunwa, C., Read, W., James, K.> ;Case Reports in Oncology. 2024 Feb 6
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
Eduardo J Medina, Youssef M Zohdy, Edoardo Porto, Juan M Revuelta Barbero, David Bray, Justin Maldonado, Alejandra Rodas, Miguel Mayol, Bryan Morales, Stewart Neill, W...> ;Frontiers in Endocrinology. 2023 Jan 1
4 citations
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastat...
Evan Rosenbaum, Rashmi Chugh, Christopher W Ryan, Mark Agulnik, Mohammed M Milhem, Suzanne George, Robin L Jones, Bartosz Chmielowski, Brian A Van Tine, Hussein Tawbi,...> ;European Journal of Cancer. 2022 Nov 1
ASO Visual Abstract: Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDB.
Mustafa Abugideiri, James Janopaul-Naylor, Jeffrey M. Switchenko, Sibo Tian, William L. Read, Robert H. Press, Shervin V. Oskouei, Nickolas B. Reimer, Matthew J. Ferri...> ;Annals of Surgical Oncology. 2021 Aug 5
4 citations
Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDB.
Mustafa Abugideiri, James Janopaul-Naylor, Jeffrey M. Switchenko, Sibo Tian, William L. Read, Robert H. Press, Shervin V. Oskouei, Nickolas B. Reimer, Matthew J. Ferri...> ;Annals of Surgical Oncology. 2021 Jul 16
12 citations
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Neeta Somaiah, Brian A. Van Tine, Amy E. Wahlquist, Mohammed M. Milhem, Elizabeth G. Hill, Elizabeth Garrett-Mayer, Kent Armeson, Scott M. Schuetze, Christian F. Meyer...> ;Cancer. 2021 Mar 15
7 citations
Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.
Andres M.Arias Lorza, Harshan Ravi, Rohit C. Philip, Jean Philippe Galons, Theodore P. Trouard, Nestor A. Parra, Daniel D. Von Hoff, William L. Read, Raoul Tibes, Rona...> ;Scientific Reports. 2020 Sep 2
4 citations
Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol.
Sam Broida, Nickolas B. Reimer, William L. Read> ;Case Reports in Oncology. 2019 Sep 17
7 citations
The use of a predictive statistical model to make a virtual control arm for a clinical trial.
Jeffrey M. Switchenko, Arielle L. Heeke, Tony Pan, William L. Read> ;Plos One. 2019 Sep 4
4 citations
The clincoradiologic spectrum of notochordal derived masses.
Samia K. Sayyid, Philip Kin-Wai Wong, William Read, David K. Monson, Monica Umpierrez, Felix M. Gonzalez, Aparna Kakarala, Adam D. Singer> ;Clinical Imaging. 2019 Jul 1
16 citations
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
Raymond Y. Huang, Prashin Unadkat, Wenya Linda Bi, Elizabeth George, Matthias Preusser, Jay D McCracken, Joseph R. Keen, William L. Read, Jeffrey J. Olson, Katharina S...> ;Neuro-Oncology. 2018 Aug 2
1292 citations
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew A. Kanner, William L. Read, David M. Steinberg, Benoit Lhermitte, Steven A. Toms, Ahmed Idbaih, Manmeet Ahluwalia, Karen Fink, F...> ;JAMA. 2017 Dec 19
1 citations
Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases.
William L. Read, Sumita Trivedi, Felicia Williams> ;Gynecologic Oncology Reports. 2017 Oct 2
179 citations
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multi...
William D. Tap, Zsuzsanna Papai, Brian A. Van Tine, Steven Attia, Kristen N. Ganjoo, Robin L. Jones, Scott M. Schuetze, Damon R. Reed, Sant P. Chawla, Richard F. Riede...> ;The Lancet. Oncology. 2017 Aug 1
4 citations
Recurrent Meningioma of the Cervical Spine, Successfully Treated With Liposomal Doxorubicin
William L. Read, Felicia Williams> ;Case Reports in Oncology. 2017 May 1
36 citations
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas
Matthias Holdhoff, Xiaobu Ye, Jeffrey G. Supko, Louis B. Nabors, Arati Desai, Tobias Walbert, Glenn J. Lesser, William L. Read, Frank S. Lieberman, Martin A. Lodge, Je...> ;Neuro-Oncology. 2017 Jun 1
11 citations
Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases.
William L. Read, Felicia Williams> ;Case Reports in Oncology. 2016 Sep 1
19 citations
Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
D Jay McCracken, Emma C. Celano, Alfredo Voloschin, William L. Read, Jeffrey J. Olson> ;Journal of Neuro-Oncology. 2016 Aug 9
6 citations
Metastatic Angiosarcoma with Kasabach-Merritt Syndrome Responsive to Gemcitabine and Vinorelbine after Failure of Liposomal Doxorubicin and Paclitaxel: A Case Report.
William L. Read, Felicia Williams> ;Case Reports in Oncology. 2016 Mar 12
7 citations
Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
William L. Read, Kevin T. Brumund, Robert A. Weisman, Angel Q. Nguyen> ;JAAD Case Reports. 2015 May 1
4 citations
Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiation.
Sonal S. Noticewala, Loren K. Mell, Scott E Olson, William L. Read> ;World Journal of Clinical Cases. 2015 Feb 16
3 citations
Public Database of Federally Funded Clinical Trials Data
William L. Read> ;Journal of Clinical Oncology. 2014 Feb 20
1 citations
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors
Nianhang Chen, Sant P. Chawla, Elena G. Chiorean, William L. Read, Mayer Gorbaty, Alain C. Mita, Lotus Yung, Peter Bryan, R. McNally, Markus F. Renschler, Sunil Sharma> ;Cancer Chemotherapy and Pharmacology. 2013 Feb 12
18 citations
A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cel...
Michele McElroy, William L. Read, Gregory S. Harmon, Noel Weidner> ;Annals of Diagnostic Pathology. 2011 Oct 1
Correlation between clinical response to EGFR inhibition and EGFR mutational status in squamous cell carcinoma of the skin.
Nguyen AQ, Read WL> ;J. Clin. Oncol.. 2011-05-20
Join now to see all

Press Mentions

Research Roundup: Recent Grants and Publications for Emory Faculty and StaffJuly 15th, 2020

Hospital Affiliations

Emory University HospitalAtlanta, Georgia
Southern Regional Medical CenterRiverdale, Georgia
Emory University Hospital MidtownAtlanta, Georgia